SCLX: Scilex Holding Company Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 103.34
Enterprise Value ($M) 224.89
Book Value ($M) -172.94
Book Value / Share -1.43
Price / Book -0.60
NCAV ($M) -227.47
NCAV / Share -1.88
Price / NCAV -0.45

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -1.33
Return on Equity (ROE) -10.32

Liquidity (mrq)
Quick Ratio 0.17
Current Ratio 0.19

Balance Sheet (mrq) ($M)
Current Assets 46.78
Assets 101.31
Liabilities 274.25
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 46.74
Operating Income -105.43
Net Income -114.33

Cash Flow Statement (mra) ($M)
Cash From Operations -20.71
Cash from Investing -0.33
Cash from Financing 23.58

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
7 days ago 13D/A SCLX Stock Acquisition JV LLC 33.30 0.00
09-26 13D/A Sorrento Therapeutics, Inc. 1.30 -97.99

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-12 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-08-11 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2023-05-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-01 178,451 562,306 31.74
2024-04-30 196,796 228,870 85.99
2024-04-29 74,399 183,207 40.61
2024-04-26 95,124 148,568 64.03

(click for more detail)

Similar Companies
SABS – SAB Biotherapeutics, Inc. SAVA – Cassava Sciences, Inc.
SBFM – Sunshine Biopharma, Inc. SEEL – Seelos Therapeutics, Inc.
SHPH – Shuttle Pharmaceuticals Holdings, Inc.


Financial data and stock pages provided by
Fintel.io